Showing results (1-10 of 616) with videos related to
Sort By:
Pageof 62
Journal of the Neurological Sciences|January 29, 2010
Knowns and unknowns in the future of multiple sclerosis treatmentOlaf StüveJournal of the Neurological Sciences|May 14, 2008
The effects of natalizumab on the innate and adaptive immune system in the central nervous systemOlaf StüveCold Spring Harbor Perspectives in Medicine|March 4, 2018
Natalizumab: Perspectives from the Bench to BedsideAfsaneh Shirani, Olaf StüveTherapeutic Advances in Neurological Disorders|October 25, 2014
Isoniazid in autoimmunity: a trigger for multiple sclerosis?Bardia Nourbakhsh, Olaf StüveJournal of Immunology (Baltimore, Md. : 1950)|February 8, 2017
Natalizumab for Multiple Sclerosis: A Case in Point for the Impact of Translational NeuroimmunologyAfsaneh Shirani, Olaf StüveCurrent Neuropharmacology|March 2, 2012
Idiopathic transverse myelitis and neuromyelitis optica: clinical profiles, pathophysiology and therapeutic choicesAmer Awad, Olaf StüveTherapeutic Advances in Neurological Disorders|December 25, 2010
Cyclophosphamide in multiple sclerosis: scientific rationale, history and novel treatment paradigmsAmer Awad, Olaf StüveDegenerative Neurological and Neuromuscular Disease|July 28, 2018
Spotlight on daclizumab: its potential in the treatment of multiple sclerosisRon Milo, Olaf StüveContinuum (Minneapolis, Minn.)|July 20, 2012
Immunopathogenesis of multiple sclerosis: new insights and therapeutic implicationsAmer M Awad, Olaf StüvePageof 62